Showing results (961-970 of 1,024) with videos related to

Sort By:
Pageof 103
Nature Communications|June 9, 2023
Persistent serum protein signatures define an inflammatory subcategory of long COVIDAarthi Talla, Suhas V Vasaikar, Gregory Lee Szeto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancerEzra E W Cohen, Theodore G Karrison, Masha Kocherginsky, et al.
Immunity|June 21, 2020
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic MutationEmilie Seydoux, Leah J Homad, Anna J MacCamy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2020
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB StudySteven F Powell, Kathryn A Gold, Mark M Gitau, et al.
Plos One|September 21, 2018
Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trialMarnie L Elizaga, Shuying S Li, Nidhi K Kochar, et al.
Parkinsonism & Related Disorders|December 2, 2015
Interprofessional education increases knowledge, promotes team building, and changes practice in the care of Parkinson's diseaseElaine V Cohen, Ruth Hagestuen, Gladys González-Ramos, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2013
Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteriaFlorine N J Frakking, Wouter C Rottier, J Wendelien Dorigo-Zetsma, et al.
Nature|November 8, 2016
PI3Kγ is a molecular switch that controls immune suppressionMegan M Kaneda, Karen S Messer, Natacha Ralainirina, et al.
European Journal of Heart Failure|January 27, 2009
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of CardiologyStephane Heymans, Emilio Hirsch, Stefan D Anker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2022
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and NeckCherie-Ann O Nathan, D Neil Hayes, Theodore Karrison, et al.
Pageof 103